BioCentury | Oct 24, 2020
Translation in Brief

UNC Chapel Hill Angelman gene therapy rescues motor function; plus data backing planned Pacylex, Kronos clinical trials and more

...against miR-132 in a Phase I trial for heart failure.Ohana sperm-based IVF treatmentReproductive health company Ohana Biosciences...
...at Chapel Hill Asklepios BioPharmaceutical Inc. Pacylex Pharmaceuticals University of Alberta Kronos Bio Inc. Massachusetts Institute of Technology Mayo Clinic University College London Ohana Biosciences Ubiquitin...
BioCentury | Apr 18, 2020
Management Tracks

PTC names Matthew Klein as chief development officer; plus Cardurion, Sangamo, TCR2, Five Prime and more

...He was VP of strategic program direction, immunology and inflammation at Regeneron Pharmaceuticals Inc. (NASDAQ:REGN). Ohana Biosciences...
BioCentury | Apr 2, 2020
Finance

Billion-dollar funds from Arch, Flagship show VCs are open for business

...Editas Medicines Inc. (NASDAQ:EDIT). Recent Flagship launches include Repertoire Immune Medicines and sperm biology company Ohana Biosciences...
BioCentury | Feb 15, 2020
Management Tracks

Immunomedics names Itri CMO; plus Hua, GenMark, AAM, Vividion, Sophia Genetics, Enterprise, Encoded, Palleon and more

...expanded its board with the appointment of Amber Salzman. She is president and CEO of Ohana Biosciences...
BioCentury | Jan 27, 2020
Emerging Company Profile

Ohana: Looking to the other half of reproductive biology

...its sperm biology platform designed to address reproductive health issues ranging from fertility to contraception. Ohana Biosciences...
BioCentury | Jul 16, 2018
Company News

Management tracks: Cerecor, Sangamo

...is succeeded as president and CEO by Jason Hanson, who was president and CEO at Ohana Biosciences...
Items per page:
1 - 6 of 6
BioCentury | Oct 24, 2020
Translation in Brief

UNC Chapel Hill Angelman gene therapy rescues motor function; plus data backing planned Pacylex, Kronos clinical trials and more

...against miR-132 in a Phase I trial for heart failure.Ohana sperm-based IVF treatmentReproductive health company Ohana Biosciences...
...at Chapel Hill Asklepios BioPharmaceutical Inc. Pacylex Pharmaceuticals University of Alberta Kronos Bio Inc. Massachusetts Institute of Technology Mayo Clinic University College London Ohana Biosciences Ubiquitin...
BioCentury | Apr 18, 2020
Management Tracks

PTC names Matthew Klein as chief development officer; plus Cardurion, Sangamo, TCR2, Five Prime and more

...He was VP of strategic program direction, immunology and inflammation at Regeneron Pharmaceuticals Inc. (NASDAQ:REGN). Ohana Biosciences...
BioCentury | Apr 2, 2020
Finance

Billion-dollar funds from Arch, Flagship show VCs are open for business

...Editas Medicines Inc. (NASDAQ:EDIT). Recent Flagship launches include Repertoire Immune Medicines and sperm biology company Ohana Biosciences...
BioCentury | Feb 15, 2020
Management Tracks

Immunomedics names Itri CMO; plus Hua, GenMark, AAM, Vividion, Sophia Genetics, Enterprise, Encoded, Palleon and more

...expanded its board with the appointment of Amber Salzman. She is president and CEO of Ohana Biosciences...
BioCentury | Jan 27, 2020
Emerging Company Profile

Ohana: Looking to the other half of reproductive biology

...its sperm biology platform designed to address reproductive health issues ranging from fertility to contraception. Ohana Biosciences...
BioCentury | Jul 16, 2018
Company News

Management tracks: Cerecor, Sangamo

...is succeeded as president and CEO by Jason Hanson, who was president and CEO at Ohana Biosciences...
Items per page:
1 - 6 of 6